Work

Supplemental Materials and Methods 1 from Breast Cancer Polygenic-Risk Score Influence on Risk-Reducing Endocrine Therapy Use: Genetic Risk Estimate (GENRE) Trial 1-Year and 2-Year Follow-Up

Year: 2024

Type: supplementary-materials

Abstract: The Supplemental Materials and Methods file depicts a representative graphical report provided to participants at Visits 1 and 2 that illustrates the participant’s estimated 5-year, 10-year, and remaining lifetime breast cancer risk (determined by NCI-BCRAT and IBIS with and without PRS).

DOI: 10.1158/1940-6207.25132751

Authors: Daniela L. Stan, Julian O. Kim, Daniel J. Schaid, Erin E. Carlson, Christina A. Kim, Jason P. Sinnwell, Fergus J. Couch, Celine M. Vachon, Andrew L. Cooke, Benjamin A. Goldenberg, Sandhya Pruthi

Language: English

Topic: BRCA gene mutations in cancer

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4391477442

Cites:

Cited by:

Related to: 10